Acasti Pharma | ACST - Ebitda

Aktienkurs
4.60
Täglich Wechseln
0.11 2.45%
Monatlich
3.60%
Jährlich
113.95%
Q2 Prognose
3.51




Ebitda Veränderung Datum
Acasti Pharma USD -2.45M 735K 2025-12
Addus HomeCare USD 50.34M 5.19M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Cassava Sciences USD -11.73M 33.44M 2025-09
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Option Care Health USD 126M 6.5M 2025-12
Organigram Holdings CAD 5.26M 884K 2025-12
Tilray USD 8.36M 1.82M 2025-09